KIF22 and Miyoshi myopathy: Mechanistically, we verified that KIF22 positively transcriptionally regulated CDC25C expression by binding its promoter, which in turn regulated the CDC25C/CDK1/cyclinB1 pathway in MM cells (Fig. 7).